Patents by Inventor Mark M. Jones

Mark M. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240193348
    Abstract: Systems and methods are disclosed for manually and programmatically remediating websites to thereby facilitate website navigation by people with diverse abilities. For example, an administrator portal is provided for simplified, form-based creation and deployment of remediation code, and a machine learning system is utilized to create and suggest remediations based on past remediation history. Voice command systems and portable document format (PDF) remediation techniques are also provided for improving the accessibility of such websites.
    Type: Application
    Filed: June 29, 2023
    Publication date: June 13, 2024
    Inventors: Sean D. Bradley, Mark D. Baker, Jeffrey O. Jones, Kenny P. Hefner, Adam Finkelstein, Douglas J. Gilormo, Taylor R. Bodnar, David C. Pinckney, Charlie E. Blevins, Helena Laymon, Trevor C. Jones, Damien M. Carrillo
  • Publication number: 20240101946
    Abstract: Cells may be grown in a bioreactor, and the cells may be activated by an activator (e.g., a soluble activator complex). Nutrient and gas exchange capabilities of a closed, automated cell expansion system may allow cells to be seeded at reduced cell seeding densities, for example. Parameters of the cell growth environment may be manipulated to load the cells into a particular position in the bioreactor for the efficient exchange of nutrients and gases. System parameters may be adjusted to shear any cell colonies that may form during the expansion phase. Metabolic concentrations may be controlled to improve cell growth and viability. Cell residence in the bioreactor may be controlled. In embodiments, the cells may include T cells. The cells may include T cell subpopulations, including regulatory T cells (Tregs), for example.
    Type: Application
    Filed: September 15, 2023
    Publication date: March 28, 2024
    Inventors: Mindy M. MILLER, Maria KNAUB, Ann Marie W. CUNNINGHAM, Mark E. JONES
  • Publication number: 20240085855
    Abstract: A wearable electronic device comprises a housing, a feedback device, a depth sensor, and a processing element. The feedback device is located in the housing and configured to generate a vibration. The depth sensor is configured to generate a signal indicative of a current depth of the housing. The processing element is in electronic communication with the feedback device and the depth sensor. The processing element is configured to determine the current depth based on the signal indicative of a current depth and control the feedback device to generate the vibration in a pattern indicative of a rate of change in depth based at least in part on the current depth.
    Type: Application
    Filed: September 8, 2022
    Publication date: March 14, 2024
    Inventors: Paul Benjamin H. Collins, Patrick M. Danko, Mark W. Gepner, Cody D. Jung, Daniel D. Jones
  • Publication number: 20240076597
    Abstract: A method for functionalizing a hollow-fiber membrane for cell expansion of targeted cells (e.g., natural killer cells) includes contacting a biotinylating molecule to a surface of the hollow-fiber membrane including an extracellular matrix component, the biotinylating molecule binding to the extracellular matrix component and having an affinity for the targeted cells. The biotinylated molecule may be selected from the group consisting of: cytokine, epitope, ligand, monoclonal antibody, stains, aptamer, and combinations thereof. The extracellular matrix component may be selected from the group consisting of: fibronectin, vitronectin, fibrinogen, collagen, laminin, and combinations thereof.
    Type: Application
    Filed: August 16, 2023
    Publication date: March 7, 2024
    Applicant: Terumo BCT, Inc.
    Inventors: Mark E. JONES, Nathan D. FRANK, Mindy M. MILLER, Ann Marie W. CUNNINGHAM, Dalip SETHI
  • Patent number: 5002755
    Abstract: Nephrotoxicity of anti-tumor platinum coordination compounds (e.g., cisplatin) is reduced by administering a dithiocarbamate chelator (e.g., diethyldithiocarbamate) at least 12 hours before as well as immediately after the administration of the anti-tumor compound.
    Type: Grant
    Filed: April 24, 1989
    Date of Patent: March 26, 1991
    Assignee: Vanderbilt University
    Inventors: William M. Mitchell, Mark M. Jones, Mark A. Basinger